Detalles de la búsqueda
1.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914801
2.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Int J Cancer
; 150(4): 645-653, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34562271
3.
Impact of adjuvant trastuzumab treatment on fatigue, emotional status and quality of personal and work life of patients with localised breast cancer: results of the 'HER-ception' study.
Support Care Cancer
; 31(1): 38, 2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525099
4.
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
Cancer
; 126(24): 5328-5336, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996583
5.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 20(1): 120-133, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477937
6.
Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program.
Eur J Cancer Care (Engl)
; 28(3): e13015, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790365
7.
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 17(12): 1732-1742, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27751846
8.
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
Support Care Cancer
; 24(3): 1131-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26268784
9.
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Lancet Oncol
; 16(4): 457-64, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795402
10.
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.
Lancet Oncol
; 16(3): 312-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25680558
11.
Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting.
Cancer
; 120(21): 3361-9, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25042799
12.
Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.
Cancer
; 120(19): 3003-6, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942887
13.
Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital.
Cancer Med
; 12(17): 17603-17612, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492987
14.
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Cancer
; 118(13): 3330-6, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22045619
15.
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).
Oncologist
; 17(9): 1213-20, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22907974
16.
[Management of adverse effects of targeted therapy toxicities in oncology]. / Principes de prise en charge des effets indésirables des thérapies ciblées en cancérologie.
Rev Prat
; 62(1): 17-25, 2012 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-22335060
17.
Supervised Physical Activity Quickly Improves Social Dimension of Quality of Life in Breast Cancer Patients.
Med Sci Sports Exerc
; 54(12): 2158-2166, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35881932
18.
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Eur J Cancer
; 150: 108-118, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33895682
19.
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years.
J Adolesc Young Adult Oncol
; 9(2): 172-182, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702419
20.
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib.
Eur J Cancer
; 126: 45-55, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918233